Frequency and factors associated with delay in breast cancer treatment in Brazil, according to data from the Oncology Panel, 2019-2020
Epidemiol Serv Saude. 2023;32(1):e2022563.
doi: 10.1590/S2237-96222023000300004.
[Article in
English,
Portuguese]
Affiliations
- 1 Universidade Federal de Juiz de Fora, Programa de Pós-Graduação em Saúde Coletiva, Juiz de Fora, MG, Brasil.
- 2 Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Detecção Precoce e Apoio a Organização de Rede, Rio de Janeiro, RJ, Brasil.
- 3 Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Pesquisa Populacional, Rio de Janeiro, RJ, Brasil.
- 4 Universidade Estadual do Rio de Janeiro, Instituto de Medicina Social Hesio Cordeiro, Rio de Janeiro, RJ, Brasil.
Abstract
Objective:
to analyze treatment delay and the flow of care for women with breast cancer in Brazil in 2019 and 2020.
Method:
this was a follow-up study of breast cancer cases available from the Oncology Panel; a chi-square test and multilevel logistic regression were performed in order to analyze the explanatory variables associated with delay (greater than 60 days) in starting treatment.
Results:
22,956 cases (54.5%) with delay in treatment were identified in 2019 and 17,722 (48.7%) in 2020; the Southeast region (54.6%) had the greatest proportion of delay; delay was greater when treatment was provided outside the municipality of residence and lower in 2020 compared to 2019; most outward flows were to the capital cities in the same Federative Units of residence.
Conclusion:
strategies to reduce cancer treatment delay and optimize health care networks in the Federative Units should be prioritized.
MeSH terms
-
Brazil / epidemiology
-
Breast Neoplasms* / epidemiology
-
Breast Neoplasms* / therapy
-
Female
-
Follow-Up Studies
-
Health Services Accessibility*
-
Humans
-
Residence Characteristics